A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the ...

The question remains: what will it take to prove that any protection device is having a meaningful impact on stroke risk?

Emboline's Emboliner system excels in a global trial, showing superior debris capture and procedural success in TAVR patients ...

In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter ...

CHICAGO, IL—Cerebral embolic protection devices are infrequently used during transcatheter aortic valve implantation procedures in the United States, and new data suggest their use does not appear to ...

CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical® today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Sentinel™ Cerebral Protection ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

Please provide your email address to receive an email when new articles are posted on . Adults who underwent transcatheter aortic valve replacement with a cerebral protection system experienced fewer ...

The FiberNet Embolic Protection System is a temporary, intravascular, 0.014-inch wire-based filter system that is placed distal to a lesion to be treated by interventional procedures (Figures 1 & 2).

(MENAFN- EIN Presswire) EINPresswire/ -- The Embolic Protection Devices Market is gaining significant traction globally, driven by the rising prevalence of cardiovascular diseases, increasing adoption ...